References
- Byrn S, Pfeiffer R, Stowell J. Solid-state chemistry of drugs. 2nd ed. Indiana: SSCI Inc.; 1999:574
- Brittain H, ed. Polymorphism in pharmaceutical solids. New York: Marcel Dekker Inc.; 1999
- Yu L. Physical characterization of polymorphic drugs: an integrated characterization strategy. Pharm Sci Technol Today 1998;1:118–127
- Cimarosti Z, Castagnoli C, Rossetti M, et al. Development of drug substances as mixture of polymorphs: studies to control form 3 in casopitant mesylate. Org Process Res Dev 2010;14:1337–1346
- Lancaster RW, Karamertzanis PG, Hulme AT, et al. Racemic progesterone: predicted in silico and produced in the solid state. Chem Commun 2006;47:4921–4923
- Lancaster RW, Karamertzanis PG, Hulme AT, et al. The polymorphism of progesterone: stabilization of a “disappearing” polymorph by co-crystallization. J Pharm Sci 2007;96:3419–3431
- Hirvonen E. Progestins. Maturitas 1996;23:S13–S18
- Payne RS, Roberts RJ, Rowe RC, Docherty R. Examples of successful crystal structure prediction: polymorphs of primidone and progesterone. Int J Pharm 1999;177:231–245
- Cameroni R, Gamberini G, Bernabei MT, Facchini M. Polymorphism of progesterone. I. Preparation and characterization of polymorphic forms. Il Farmaco Edizione Pratica 1973;28:621–635
- Barrio M, Espeau P, Tamarit JL, et al. Polymorphism of progesterone: relative stabilities of the orthorhombic phases I and II inferred from topological and experimental pressure–temperature phase diagrams. J Pharm Sci 2009;98:1657–1670
- Heredia V, Bianco ID, Tríbulo H, et al. Polyisoprene matrix for progesterone release: in vitro and in vivo studies. Int J Pharm 2009;382:98–103
- Tripathi R, Biradar SV, Mishra B, Paradkar AR. Study of polymorphs of progesterone by novel melt sonocrystallization technique: a technical note. AAPS Pharm Sci Tech 2010;11:1493–1498
- Larson AC, Von Dreele RB. General structure analysis system (GSAS) structure. Los Alamos National Laboratory; 2004:86–748
- Toby BH. EXPGUI, a graphical user interface for GSAS. J Appl Crystallogr Int Union Crystallogr 2001;34:210–213
- Stephens PW. Phenomenological model of anisotropic peak broadening in powder diffraction. J Appl Crystallogr 1999;32:281–289
- Harris R. Nuclear magnetic resonance spectroscopy. London: Longman Scientific and Technical; 1994
- Bräuniger T, Wormald P, Hodgkinson P. Improved proton decoupling in NMR spectroscopy of crystalline solids using the S PINAL-64 sequence. Monatsh Chem 2002;133:1549–1554
- Legendre B, Feutelais Y, Defossemont G. Importance of heat capacity determination in homogeneous nucleation: application to progesterone. Thermochim Acta 2003;400:213–219
- USP. United State Pharmacopeia. 30th ed. Rockville: United State Convention; 2007
- Taghizadeh SM, Mashak A, Jamshidi A, Imani M. Study of progesterone release mechanisms from a silicone matrix by a new analytical method. J Appl Polym Sci 2004;91:3040–3044
- Farmacopeia Brasileira, Volume 2/Agência Nacional de Vigilância Sanitária, Anvisa, Brasília; 2010
- Wang F, Wachter JA, Antosz FJ, Berglund KA. An investigation of solvent-mediated polymorphic transformation of progesterone using in situ Raman spectroscopy. Org Process Res Dev 2000;4:391–395
- Narang AS, Rao VM, Raghavan KS. Excipient compatibility. Developing solid oral dosage forms pharmaceutical theory and practice. 1st ed. Oxford: Elsevier Inc.; 2009:125–145
- Yu L. Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs. Int J Pharm 2004;270:221–227
- Defossemont G, Randzio SL, Legendre B. Contributions of calorimetry for Cp determination and of scanning transitiometry for the study of polymorphism. Cryst Growth Des 2004;4:1169–1174
- Reading M, Craig DQM. Principles of differential scanning calorimetry. Thermal analysis of pharmaceuticals. 1st ed. Boca Raton: Taylor and Francis; 2007:1–22
- Brittain HG. Polymorphism and solvatomorphism 2010. J Pharm Sci 2012;101:464–484
- Muramatsu M, Iwahashi M, Takeuchi U. Thermodynamic relationship between alpha- and beta-forms of crystalline progesterone. J Pharm Sci 1979;68:175–177
- Sehić S, Betz G, Hadzidedić S, et al. Investigation of intrinsic dissolution behavior of different carbamazepine samples. Int J Pharm 2010;386:77–90
- Lancaster RW, Harris LD, Pearson D. Fifty-year old samples of progesterone demonstrate the complex role of synthetic impurities in stabilizing a metastable polymorph. Cryst Eng Comm 2011;13:1775
- Dunitz JD, Bernstein J. Disappearing polymorphs. Acc Chem Res 1995;28:193–200